Aims: The authors describe the occurrence of diabetes and obesity in the population of Northern Sweden and the role of diabetes in cardiovascular disease. Methods: Four surveys of the population aged 25 to 64 years were undertaken during a 14-year time span. Stroke events in subjects 35 -74 years during 1985 -92 and myocardial infarction in subjects 25 -64 years 1989 -93 were registered. Results: The prevalence of diagnosed diabetes was 3.1 and 2.0% in men and women, respectively, and 2.6 and 2.7% for previously undiagnosed diabetes. During the 13-year observation period, BMI increased 0.96 kg/m 2 in men and 0.87 in women. The proportion of subjects with obesity (BMI¢30) increased from 10.3% to 14.6% in men and from 12.5% to 15.7% in women. Hip circumference increased substantially more than waist circumference, leading to a decreasing waits-to-hip ratio (WHR). The relative risk for stroke or myocardial infarction was four to six times higher in a person with diabetes than in those without diabetes. The 28-day case fatality for myocardial infarction, but not for stroke, was significantly higher in both men and women with diabetes. Population-attributable risk for diabetes and stroke was 18% in men and 22% in women and for myocardial infarction it was 11% in men and 17% in women. Conclusion: Obesity is becoming more common, although of a more distal than central distribution. The burden of diabetes in cardiovascular diseases in Northern Sweden is high.
INTRODUCTION
Diabetes mellitus is a disease with vast consequences, for both patients and society. More than 85% of all diabetes is type 2 diabetes, which is most common among elderly people. Thus, the burden of disease is mainly determined by occurrence of type 2 diabetes. Direct medical costs for type 2 diabetes in Sweden 1998 were estimated at SKr 7 billion (1) and total societal costs for all diabetes in Sweden year 2000 are approximately SKr 11.5 billion (US$ 1~SKr 10) (2) .
Longitudinal studies have shown that obesity and physical inactivity, in addition to hereditary factors, are the most important predictors of development of type 2 diabetes (3, 4) . In most parts of the industrialized world, body weight has been increasing for many years, prominently so in the United States (5, 6) . Also in some of the developing countries, especially in the Pacific and among indigenous peoples, obesity has rapidly become common. Changes in socioeconomic and cultural patterns, sometimes termed ''coca-colonization'', have been pointed out as the most important factors behind this epidemic of obesity. There are indications of increasing obesity also in the populations of Northern Europe in spite of efforts and campaigns to reduce cardiovascular risk factors (5, 7 -10) .
It has long been known that diabetes increases the risk for stroke (11, 12) . This increased risk seems to be restricted to cerebral infarction and does not include subarachnoid haemorrhage and haemorrhagic stroke (13 -15) . In patients with diabetes, a higher mortality in stroke (16) and a more severe course of the disease has been noted (17, 18) . Earlier studies have been based on cross-sectional or cohort studies of small populations. The validity of these findings on a population level remains doubtful, though.
Already in the early reports in 1979 from the Framingham study, diabetes was identified as an independent risk factor for coronary heart disease (12) . Soon thereafter Barret-Connor pointed out the higher relative risk of death in women with diabetes compared with men with diabetes (16) . Few studies have focused on gender differences in the impact of diabetes on acute myocardial infarction (AMI) and few studies have been published on the contribution of diabetes to the burden of AMI in society.
This paper presents unpublished data on diabetes and obesity prevalence and summarizes our previously published data on the relationship between diabetes in the population and the burden of disease from stroke and myocardial infarction associated with diabetes (19, 20) .
METHODS
The Northern Sweden MONICA Project was performed in Vä sterbotten and Norrbotten, the two most northerly counties of Sweden, with a total population of around half a million inhabitants and a high prevalence of cardiovascular disease. Population surveys were performed in 1986, 1990, 1994, and 1999 . In each of the age groups 25 -34, 35 -44, 45 -54 , and 55 -64 years 250 men and 250 women were randomly selected and invited to participate. In 1994 and 1999, the age group 65 -74 was also included. Participants were asked to complete a questionnaire including, among others, the question: ''Do you have diabetes mellitus?'' Subjects who answered yes to this question make up the group designated ''known diabetes''. They also had to indicate which treatment they had for their diabetes. Details of anthropometric measurements and the OGTT are given elsewhere (21) . The results were classified according to WHO criteria from 1999 (22):
. normal glucose tolerance: venous fasting plasma glucose v7 mmol/l and post-load venous plasma glucose v7.8 mmol/l; . impaired glucose tolerance (IGT): fasting v7 mmol/l and post-load 7.8 -11.0 mmol/l; . diabetes mellitus: fasting ¢7.0 mmol/l or post-load ¢11.1 mmol/l. Subjects diagnosed as having diabetes according to the results of the OGTT make up the group designated ''(previously) undiagnosed diabetes''. The MONICA stroke registry during an eight-year study period, 1985 -92, included 3,900 men and 2,470 women in the 35 -74 year age range who fulfilled the MONICA criteria for an acute stroke (21) . From 1 April 1989 to 31 December 1993 all AMI events in subjects 35 to 64 years old were registered (20) . For analysis on stroke and myocardial infarction the prevalence of known diabetes and previously unknown diabetes were estimated from the surveys in 1990 and 1994.
STATISTICS
Data are given as proportions with 95% confidence intervals. The Mantel-Haenszel chi-squared test for linear trends for proportions and logistic regression with diabetes as dependent variable was carried out with the programme SPSS 9.0.
RESULTS

Prevalence of known diabetes
In all four surveys, 6,952 subjects (77.2% of those invited) were examined. Of these 6,914 answered the question as to whether they had diabetes or not. The prevalence of known diabetes over the time period 1986 to 1999 for ages 25 -64 years in men and women respectively was 3.1% and 2.0% (Table I) . Total prevalence for the age group 25 -74 years, calculated from the last two surveys, was 3.8% and 3.3%, in men and women respectively. Diabetes was more common among the elderly with a distinct increase above the age of 55 years in men and above 65 years in women.
Prevalence of previously unknown diabetes
In the 1999 survey, no OGTT was performed, thus leaving 5,129 subjects in the three earlier surveys eligible for an OGTT, which was carried out in 2,419 randomly selected subjects. The prevalence of previously unknown diabetes in the age group 25 -64 years over the time period 1986 to 1994 was 2.6% and 2.7% in men and women, respectively (Table II) . There was a curvilinear increase with age in the prevalence of unknown diabetes.
Prevalence of impaired glucose tolerance
The prevalence of impaired glucose tolerance (IGT) in men increased linearly from 1.3% (0.4; 3.7) in the youngest age group to 7.9% (5.3; 11.5) in the group aged 55 -64 years (Table III) . Corresponding figures in women showed a steady prevalence of approximately 6% between 25 and 54 years and thereafter a sharp increase to 14.2% (10.7; 18.7) in subjects aged 55 -64 years.
Prevalence of obesity
During the 13 years of observation, mean weight increased linearly in consecutive cohorts aged 25 to 64 ( Figure 1a ). In 1999, men were on average 4.5 kg heavier (CI for the difference 3.3; 5.7) than in 1986 and women 3.3 kg heavier (2.1; 4.6). The trend was similar in all age groups although more prominent among the youngest (data not shown). During the same period, mean height increased by 1.5 cm (0.8; 2.2) in men and by 1.2 cm (0.5; 1.8) in women.
Similar linear increases were observed for mean BMI in age groups 25 -64 years (Figure 1b) . The difference between 1986 and 1999 amounted to 0.96 kg/m 2 (0.61; 1.31) in men and 0.87 kg/m 2 (0.43; 1.31) in women. The increase was most marked among the youngest men and among women 25 -44 years of age. It was not discernible among older women. The proportion of subjects with obesity (BMI¢30) increased from 10.3 to 14.6% (CI for the difference 1.0; 7.7) in men and from 12.5 to 15.7% in women (0.3; 6.7) ( Figure 1c ).
Among men and women 65 -74 years old, weight and BMI increased slightly but insignificantly between 1994 and 1999 and the prevalence of obesity was (Figure 1d ). Thereafter, an increase was noted in both genders although the trend was significant only for men. Hip circumference increased over the period in men by 5.2 cm (4.6; 5.7) and in women by 4.4 cm (3.5; 5.3) ( Figure 1e ). Also in this case, the increase was most marked in two youngest age groups. As the increase in hip circumference was larger than the increase in waist circumference, waist -hip ratio decreased during the period (Figure 1f ). In the oldest age group, 65 -74 years, hip but not waist circumference increased in both men and women between 1994 and 1999.
Diabetes as a risk factor for stroke
Of all stroke patients, during an eight-year period, in the age group 35 -74 years (n~6,370) 1,544 subjects had diabetes and 4,826 subjects had no known diabetes (19) . The crude incidence of stroke was four times higher in men with diabetes than in men without diabetes (Table IV) . The relative risk for stroke (all events) in men with diabetes was 4.4 (95% CI 3.6; 5.4). Among women with diabetes, the crude incidence was five times higher than women without diabetes. The relative risk for stroke in women with diabetes was 5.8 (95% CI 3.7; 6.9). Intracerebral haemorrhage was less prevalent in patients with diabetes while recurrent stroke was more common.
Of all stroke events in subjects 35 -74 years of age with diabetes, only 4% occurred in men and 2% in women with type 1 diabetes. In the age group 35 -44 years, 76% of all diabetic stroke patients had type 1 diabetes. Concomitant disorders such as atrial fibrillation, hypertension, heart failure, and myocardial infarction were all more common in stroke patients with diabetes than in those without diabetes.
There was no difference regarding 28-day case fatality between subjects with or without diabetes with one exception. In women 35 -64 years of age, the 28-day case fatality was 12.6% in subjects with no diabetes and 19.7% in those with diabetes (p~0.046). The overall mortality from stroke (first and recurrent) in the population with diabetes was 4.4 times higher in male and 5.1 times higher in female patients. Population-attributable risk for diabetes and stroke was 18% in men and 22% in women.
Diabetes as a risk factor for myocardial infarction
During the period 1989 to 1993, in total 2,415 men and 616 women fulfilled the criteria for AMI (first ever or recurrent) (20) . Diabetes was present in 363 men (15.0%) and 125 women (20.2%). Among individuals with their first-ever AMI, diabetes was present in 13% of men and 17% of women; 10% of these were classified as type 1 diabetes.
The crude AMI attack rate (first and recurrent events) was higher in men with diabetes compared with men with no diabetes and the relative risk was 3.7 (95% CI 3.3 -4.1) (Table IV) . Similar results were found in women, relative risk 6.1 (95% CI 5.0 -7.5). The crude incidence of first-ever AMI was more than three times higher in men with diabetes than in men without diabetes. Among women with diabetes, the crude incidence of first ever AMI was five times higher. The rate of recurrent events was more than five times higher in men and nine times higher in women with diabetes compared with subjects with no diabetes. After adjusting for early case fatality (before 28 days) the risk was doubled in subjects with diabetes.
The overall 28-day case fatality was significantly higher in both men and women with diabetes compared with those with no diabetes. After the first AMI this difference reached conventional statistic significance only in men, which was also the case for one-year case fatality. In contrast, 28-day case fatality in recurrent AMIs differed little with respect to whether diabetes was present or not. Total mortality was 4.3 times higher in men with diabetes versus no diabetes and 7.3 times higher in women with diabetes. The populationattributable risk for diabetes in AMI was calculated to be 11% in men and 17% in women in the 35 -64 year age group.
DISCUSSION
Our data show that obesity has become increasingly common in Northern Sweden during the period 1986 to 1999, although more of a distal than an abdominal type. The prevalence of diabetes is strongly age related and differs little according to gender. For every patient with known diabetes there is one subject with undiagnosed diabetes. Patients with diabetes are overrepresented among subjects with myocardial infarction and stroke and the prognosis is more sinister than in patients without diabetes. Diabetes is responsible for a large proportion of stroke and myocardial infarction, as judged by the population-attributable risk of nearly 20% for stroke and 12 % for MI.
The prevalence of diabetes is similar all over Northern Scandinavia
The prevalence of known diabetes was 3.8% in men and 3.3% in women aged between 25 and 74 years of age. The most comparable data come from previous Swedish studies based on thorough registries in health centres and hospital clinics where data from 1977 to 1995 are remarkably similar to ours in all age and gender groups (see Table I ) (23 -25) . Also, in 1992 -95, the Vä sterbotten Intervention Project (VIP) examined 22,000 subjects aged between 30 and 60 years in one of the two counties included in the present paper, and found the same prevalence of known diabetes (26, 27) . From mid-Norway a very similar prevalence was reported (7) . We conclude that diagnosed diabetes is as common in Northern Sweden as in other parts of northern Scandinavia, independent of when studies were done, but considerably less common than in the US NHANES study from 1988 to 1994 (see Table I ) (28) . Previously unknown diabetes, which can only be estimated from an OGTT, was as common in Northern Sweden as known diabetes, which is in accordance with previous Swedish and US investigations (see Table II ) (27 -29) . Estimations of the total prevalence can only be done in studies combining self-reported diabetes with results from OGTT, or at least singular blood glucose measurements. Based on the 1986 -94 data, the total prevalence was 5.7% in men and 4.7% in women aged 25 -64 years. These figures are higher than those reported from the Laxå study in 1987 (30) but similar to Danish data from 1996 (9) . Recent Swedish data are scant but the VIP study found a total prevalence of diabetes, between the ages of 30 and 60 years, of 5% in men and 3.9% in women (27) . Estimates from the USA show considerably higher total diabetes prevalence in corresponding American age groups, especially in women (28) .
Increasing distal obesity caused by lifestyle changes?
Compared with other MONICA centres and based on the 1990 survey, obesity was less common in Northern Sweden (5, 31) . The increase in obesity was similar to that found in the Gothenburg MONICA study (32) and corroborates reports from the UK and The Netherlands with an increase in obesity from the early 1980s, especially in younger people (5) . Repeated measurements in the USA show a slight increase in the prevalence of overweight from 1960 to 1980 but a striking increase in the period 1988 -91 (6) . Thus, the secular trend of more obesity in Northern Sweden fits well into a pattern for the industrialized world. As recently summarized, this obesity poses imminent threats for many acute and chronic conditions such as diabetes, gallstones, hypertension, heart disease, colon cancer, and stroke (4) . The impact of obesity on the burden of disease will thus probably increase and costeffective interventions on a population level to prevent individuals becoming overweight are urgently needed.
In comparison with other MONICA populations, the mean waist circumference was average while hip circumference was lower (31) . Swedish women increased their waist circumference and decreased hip circumference between 1968 and 1992, leading to an increase in WHR independent of BMI (33) . From Gothenburg, an increasing WHR was reported in both men and women between 1990 and 1995 (32) . It was thus unexpected that the increasing BMI in Northern Sweden was associated with an increase in distal and not central, or abdominal, obesity. This may relate to less saturated fat in the diet, less smoking, and higher intake of carbohydrates with low glycaemic index (34) . As great waist circumference, or WHR, is a predictor of type 2 diabetes in both men and women, independent of BMI (35, 36) , this may explain why we found no evidence of an increase in the prevalence of diabetes during the study period (37) . This is a hopeful finding, showing that the association between overweight and disease may be modifiable.
Diabetes contributes strongly to stroke and myocardial infarction
Our results confirm previous reports on stroke and diabetes and extend them to a population level. Having diabetes increases the risk for stroke four to six times, more so in women. A population-attributable risk of around 20% indicates that the total incidence of stroke would decrease by one-fifth if diabetes did not exist at all in the population. Improved metabolic control in diabetes shows little promise of improving this dismal outcome but intensified treatment of hypertension led to a clear decrease of stroke in patients with type 2 diabetes in the UKPDS study (38, 39) .
Diabetes was common in patients with MI and the increase in risk for MI in a person with diabetes was equivalent to that for stroke. Case fatality during the first 28 days in the population-based MONICA study was considerably higher in subjects with diabetes and first MI than in those without diabetes, which was supported in a recent report (40) . These findings have been used as a basis for the recommendation to treat patients with diabetes and no known CHD like patients with known MI or coronary disease, i.e. implement secondary prevention measures.
It was also clear that the impact of diabetes was more prominent in women. This was recently emphasized in a report from the Nurses' Health Study where a 20-year follow-up showed a relative risk for total mortality of 3.4 for women with diabetes and no CHD at baseline (41) . This increased to 6.8 if both diabetes and CHD were present at baseline. Corresponding risk increases for fatal CHD were 8.7 and 25.8 and adjusting for other risk factors only modestly attenuated the relative risks.
Diabetes is a strong risk factor for cardiovascular disease. It is questionable whether its detrimental effects are amenable by more intensive treatment with current therapies. In a long-term perspective, its prevention by non-pharmacological measures in high-risk individuals may be more cost-effective (42) .
